{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:16:38Z","timestamp":1790100998082,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX105-10227PC"],"award-info":[{"award-number":["NHRI-EX105-10227PC"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1434-6","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T08:03:33Z","timestamp":1550649813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Chien-Ning","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiou-Huei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Lin","family":"Tain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E Wuhl","year":"2009","unstructured":"Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361:1639\u201350.","journal-title":"N Engl J Med"},{"key":"1434_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2215\/CJN.06620909","volume":"5","author":"NJ Webb","year":"2010","unstructured":"Webb NJ, Lam C, Loeys T, Shahinfar S, Strehlau J, Wells TG, et al. Randomized, double-blind, controlled study of losartan in children with proteinuria. Clin J Am Soc Nephrol. 2010;5:417\u201324.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1434_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ki.2012.210","volume":"82","author":"NJ Webb","year":"2012","unstructured":"Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, et al. Losartan and enalapril are comparable in reducing proteinuria in children. Kidney Int. 2012;82:819\u201326.","journal-title":"Kidney Int"},{"key":"1434_CR4","doi-asserted-by":"crossref","unstructured":"Abraham AG, Betoko A, Fadrowski JJ, Pierce C, Furth SL, Warady BA, et al. Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Pediatr Nephrol. 2016.","DOI":"10.1007\/s00467-016-3512-4"},{"key":"1434_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44\u20137.","journal-title":"Value Health"},{"key":"1434_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11892-015-0621-6","volume":"15","author":"KA Datye","year":"2015","unstructured":"Datye KA, Moore DJ, Russell WE, Jaser SS. A review of adolescent adherence in type 1 diabetes and the untapped potential of diabetes providers to improve outcomes. Curr Diab Rep. 2015;15:51.","journal-title":"Curr Diab Rep"},{"key":"1434_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jpeds.2014.05.020","volume":"e501","author":"N Walders-Abramson","year":"2014","unstructured":"Walders-Abramson N, Venditti EM, Ievers-Landis CE, Anderson B, El Ghormli L, Geffner M, et al. Relationships among stressful life events and physiological markers, treatment adherence, and psychosocial functioning among youth with type 2 diabetes. J Pediatr 165. 2014;e501:504\u20138.","journal-title":"J Pediatr 165"},{"key":"1434_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/petr.12480","volume":"19","author":"KA Loiselle","year":"2015","unstructured":"Loiselle KA, Gutierrez-Colina AM, Eaton CK, Simons LE, Devine KA, Mee LL, et al. Longitudinal stability of medication adherence among adolescent solid organ transplant recipients. Pediatr Transplant. 2015;19:428\u201335.","journal-title":"Pediatr Transplant"},{"key":"1434_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1542\/peds.2013-1451","volume":"132","author":"ME McGrady","year":"2013","unstructured":"McGrady ME, Hommel KA. Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics. 2013;132:730\u201340.","journal-title":"Pediatrics"},{"key":"1434_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1331\/JAPhA.2012.10211","volume":"52","author":"SL Cutrona","year":"2012","unstructured":"Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN, et al. Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc (2003). 2012;52:381\u201397.","journal-title":"J Am Pharm Assoc (2003)"},{"key":"1434_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2215\/CJN.05750513","volume":"9","author":"TD Blydt-Hansen","year":"2014","unstructured":"Blydt-Hansen TD, Pierce CB, Cai Y, Samsonov D, Massengill S, Moxey-Mims M, et al. Medication treatment complexity and adherence in children with CKD. Clin J Am Soc Nephrol. 2014;9:247\u201354.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1434_CR12","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2215\/CJN.01150114","volume":"9","author":"OM Akchurin","year":"2014","unstructured":"Akchurin OM, Schneider MF, Mulqueen L, Brooks ER, Langman CB, Greenbaum LA, et al. Medication adherence and growth in children with CKD. Clin J Am Soc Nephrol. 2014;9:1519\u201325.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1434_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487\u201397.","journal-title":"N Engl J Med"},{"key":"1434_CR14","unstructured":"National Health Insurance Research Database (NHIRD) in Taiwan."},{"key":"1434_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1471-2458-12-288","volume":"12","author":"SH Huang","year":"2012","unstructured":"Huang SH, Hsu CN, Yu SH, Cham TM. Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan. BMC Public Health. 2012;12:288.","journal-title":"BMC Public Health"},{"key":"1434_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-148-4-200802190-00004","volume":"148","author":"CP Wen","year":"2008","unstructured":"Wen CP, Tsai SP, Chung WS. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med. 2008;148:258\u201367.","journal-title":"Ann Intern Med"},{"key":"1434_CR17","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51:S11\u201321.","journal-title":"Med Care"},{"key":"1434_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/CEOR.S15619","volume":"3","author":"L Degli Esposti","year":"2011","unstructured":"Degli Esposti L, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bari M, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011;3:47\u201354.","journal-title":"Clinicoecon Outcomes Res"},{"key":"1434_CR19","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/CJN.07100810","volume":"6","author":"SL Furth","year":"2011","unstructured":"Furth SL, Abraham AG, Jerry-Fluker J, Schwartz GJ, Benfield M, Kaskel F, et al. Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:2132\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"92\u201397","key":"1434_CR20","volume":"167","author":"CP Dobson","year":"2015","unstructured":"Dobson CP, Eide M, Nylund CM. Hypertension prevalence, cardiac complications, and antihypertensive medication use in children. J Pediatr. 2015;167(92\u201397):e91.","journal-title":"J Pediatr"},{"key":"1434_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2011-0877","volume":"129","author":"EY Yoon","year":"2012","unstructured":"Yoon EY, Cohn L, Rocchini A, Kershaw D, Freed G, Ascione F, et al. Antihypertensive prescribing patterns for adolescents with primary hypertension. Pediatrics. 2012;129:e1\u20138.","journal-title":"Pediatrics"},{"key":"1434_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/kisup.2012.46","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337\u2013414.","journal-title":"Kidney Int Suppl"},{"key":"1434_CR23","doi-asserted-by":"crossref","unstructured":"Jarari N, Rao N, Peela JR, Ellafi KA, Shakila S, Said AR, et al. A review on prescribing patterns of antihypertensive drugs. Clin Hypertens. 2015;22.","DOI":"10.1186\/s40885-016-0042-0"},{"key":"1434_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/pch\/13.1.19","volume":"13","author":"M Egedy M","year":"2008","unstructured":"Egedy M M, Frappier J-Y. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13:19\u201324.","journal-title":"Paediatr Child Health"},{"key":"1434_CR25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00467-016-3325-5","volume":"31","author":"HH Chou","year":"2016","unstructured":"Chou HH, Lin CY, Chiou YH, Tain YL, Wang YF, Wang HH, et al. Clinical characteristics and prevalence of complications of chronic kidney disease in children: the Taiwan pediatric renal collaborative study. Pediatr Nephrol. 2016;31:1113\u201320.","journal-title":"Pediatr Nephrol"},{"key":"1434_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.110635","volume":"52","author":"JT Flynn","year":"2008","unstructured":"Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension. 2008;52:631\u20137.","journal-title":"Hypertension"},{"key":"1434_CR27","first-page":"140","volume":"e20171904","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and Management of High Blood Pressure in children and adolescents. Pediatrics. 2017;e20171904:140.","journal-title":"Pediatrics"},{"key":"1434_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00467-014-2982-5","volume":"30","author":"N Ibrahim","year":"2015","unstructured":"Ibrahim N, Wong IC, Tomlin S, Sinha MD, Rees L, Jani Y. Epidemiology of medication-related problems in children with kidney disease. Pediatr Nephrol. 2015;30:623\u201333.","journal-title":"Pediatr Nephrol"},{"key":"1434_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/bcp.12270","volume":"77","author":"AN Rashed","year":"2014","unstructured":"Rashed AN, Wilton L, Lo CC, Kwong BY, Leung S, Wong IC. Epidemiology and potential risk factors of drug-related problems in Hong Kong paediatric wards. Br J Clin Pharmacol. 2014;77:873\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1434_CR30","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/ndt\/gfu330","volume":"30","author":"EO Gosmanova","year":"2015","unstructured":"Gosmanova EO, Kovesdy CP. Adherence to antihypertensive medications: is prescribing the right pill enough? Nephrol Dial Transplant. 2015;30:1649\u201356.","journal-title":"Nephrol Dial Transplant"},{"key":"1434_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/HJH.0000000000000382","volume":"33","author":"M Krousel-Wood","year":"2015","unstructured":"Krousel-Wood M, Holt E, Joyce C, Ruiz R, Dornelles A, Webber LS, et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the cohort study of medication adherence among older adults (CoSMO). J Hypertens. 2015;33:412\u201320.","journal-title":"J Hypertens"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1434-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T19:08:09Z","timestamp":1582139289000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1434-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1434-6","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"assertion":[{"value":"3 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Chang Gung Medical Foundation, Institute\u2019s Ethical Committee, and informed consent was waived due to the retrospective study design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"64"}}